Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Diseas...

by Claggett, B., Diaz, R., Dickstein, K., Gerstein, H.C, Køber, L., Lewis, E.F, Maggioni, A.P, McMurray, J.J.V, Pfeffer, M.A, Probstfield, J.L, Riddle, M.C, Solomon, S.D, Tardif, J.-C, Wolsk, E.
Published 2022

Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial

by Berwanger, O., Braunwald, E., Cikes, M., Claggett, B., De Pasquale, C.G, Fernandez, A., Filippatos, G., Granger, C.B, Jering, K., Køber, L., Landmesser, U., Lefkowitz, M., Lewis, E.F, Maggioni, A.P, Mann, D.L, McMurray, J.J.V, Menon, V., Merkely, B., Petrie, M.C, Petrov, I., Pfeffer, M.A, Rouleau, J.-L, Schou, M., Senni, M., Sim, D., Solomon, S.D, Steg, P.G, van der Meer, P., Wang, Y., Zhou, Y.
Published 2022

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

by COMPASS Investigators, Alings, M, Anand, SS, Avezum, A, Bhatt, DL, Bosch, J, Branch, KRH, Bruns, NC, Commerford, PJ, Connolly, SJ, Dagenais, GR, Dans, AL, Diaz, R, Dyal, L, Eikelboom, JW, Ertl, G, Felix, C, Fox, KAA, Guzik, TJ, Hart, RG, Hori, M, Kakkar, AK, Keltai, M, Kim, JH, Lanas, F, Leong, D, Lewis, BS, Liang, Y, Lonn, EM, Lopez-Jaramillo, P, Maggioni, AP, Metsarinne, KP, Moayyedi, P, Muehlhofer, E, O'Donnell, M, Parkhomenko, AN, Piegas, LS, Pogosova, N, Probstfield, J, Ryden, L, Shestakovska, O, Steg, PG, Stork, S, Tonkin, AM, Torp-Pedersen, C, Verhamme, PB, Vinereanu, D, Widimsky, P, Yusoff, K, Yusuf, S, Zhu, J
Published 2019

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

by COMPASS Investigators, Alings, M, Anand, SS, Avezum, A, Bhatt, DL, Bosch, J, Branch, KRH, Bruns, NC, Commerford, PJ, Connolly, SJ, Dagenais, GR, Dans, A, Diaz, R, Dyal, L, Eikelboom, JW, Ertl, G, Felix, C, Fox, KAA, Guzik, T, Hart, RG, Hori, M, Kakkar, A, Keltai, M, Kim, JH, Lanas, F, Leong, D, Lewis, BS, Liang, Y, Lonn, EM, Lopez-Jaramillo, P, Maggioni, AP, Metsarinne, K, Moayyedi, P, Muehlhofer, E, ODonnell, M, Parkhomenko, AN, Piegas, LS, Pogosova, N, Probstfield, J, Ryden, L, Shestakovska, O, Steg, PG, Stork, S, Tonkin, AM, Torp-Pedersen, C, Verhamme, PB, Vinereanu, D, Widimsky, P, Yusoff, K, Yusuf, S, Zhu, J
Published 2019

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Hart, R.G, Hori, M., Kakkar, A.K, Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Cook Bruns, N., Dagenais, G.R, Dans, A., Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T., Hart, R.G, Hori, M., Kakkar, A., Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K., Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

by Aboyans, V., Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Chen, E., Commerford, P.J, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Ha, J.-W, Hart, R.G, Hori, M., Kakkar, A., Keltai, K., Keltai, M., Kim, J.-H, Lamy, A., Lanas, F., Lanius, V., Leong, D.P, Lewis, B.S, Liang, Y., Liu, L., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Misselwitz, F., Moayyedi, P., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J.L, Ryden, L., Sharma, M., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Varigos, J.D, Verhamme, P.B, Vinereanu, D., Widimsky, P., Yuan, F., Yusoff, K., Yusuf, S., Zhu, J.
Published 2017